Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells

Biochemical and Biophysical Research Communications

Volumn 433, Issue 1, 2013, Pages 24-30

  Yang, Wen Hao ^a   Lan, Hsin Yi ^a   Tai, Shyh Kuan ^b   Yang, Muh Hwa ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

BMP4; Let 7i; Mesenchymal migration

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; LET 7I PROTEIN; MICRORNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; ATTENUATION; BIOINFORMATICS; CANCER CELL; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BONE MORPHOGENETIC PROTEIN 4; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MESODERM; MICRORNAS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR;

EID: 84875813637     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.076     Document Type: Article

References (33)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics. CA Cancer J. Clin. 2010, 60:277-300.
2. Goldenberg D., Lee J., Koch W.M., et al. Habitual risk factors for head and neck cancer. Otolaryngol. Head Neck Surg. 2004, 131:986-993.
3. Garavello W., Ciardo A., Spreafico R., et al. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2006, 132:762-766.
4. Evan-Ram S., Yamada K.M. Cell migration in 3D matrix. Curr. Opin. Cell Biol. 2005, 17:524-532.
5. Slorach E.M., Chou J., Werb Z. Zepp o1 is a metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev. 2011, 25:471-484.
6. Wolf K., Wu Y.I., Liu Y., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 2007, 9:893-904.
7. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 2010, 188:11-19.
8. Sanz-Moreno V., Gadea G., Ahn J., et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 2008, 135:510-523.
9. Sanz-Moreno V., Marshall C.J. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr. Opin. Cell Biol. 2010, 22:690-696.
10. Panková K., Rösel D., Novotný M., et al. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell. Mol. Life Sci. 2010, 67:63-71.
11. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
12. Iorio M.V., Croce C.M. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 2009, 27:5848-5856.
13. Lu J., Getz G., Miska E.A., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
14. Dykxhoorn D.M. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res. 2010, 70:6401-6406.
15. Sokol N.S., Xu P., Jan Y.N., et al. Drosophila let-7 microRNA is required for remodeling of the neuromusculature during metamorphosis. Genes Dev. 2008, 22:1591-1596.
16. Caygill E.E., Johnston L.A. Temporal regulation of metamorphic processes in Drosophila by the let-7 and miR-125 heterochronic microRNAs. Curr. Biol. 2008, 18:943-950.
17. Peter M.E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852.
18. Yang W.H., Lan H.Y., Huang C.H., et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat. Cell Biol. 2012, 14:366-374.
19. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996, 10:1580-1594.
20. Reinhold W.C., Sunshine M., Liu H., et al. Cell Miner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. Cancer Res. 2012, 72:3499-3511.
21. Chen C., Ridzon D.A., Broomer A.J., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33:e179.
22. Huang C.H., Yang W.H., Chang S.Y., et al. Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 2009, 11:1371-1382.
23. Plaisier C.L., Pan M., Baliga N.S. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. Genome Res. 2012, 22:2302-2314.
24. Vicente López M.A., Vázquez García M.N., Entrena A., et al. Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency. Stem Cells Dev. 2011, 20:1011-1019.
25. Sneddon J.B., Zhen H.H., Montgomery K., et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc. Natl. Acad. Sci. 2006, 103:14842-14847.
26. Kwak C., Park Y.H., Kim I.Y., et al. Expression of bone morphogenetic proteins, the subfamily of the transforming growth factor-beta superfamily, in renal cell carcinoma. J. Urol. 2007, 178:1062-1067.
27. Kim S.G., Park H.R., Min S.K., et al. Expression of bone morphogenic protein-4 is inversely related to prevalence of lymph node metastasis in gastric adenocarcinoma. Surg. Today 2011, 41:688-692.
28. Laatio L., Myllynen P., Serpi R., et al. BMP-4 expression has prognostic significance in advanced serous ovarian carcinoma and is affected by cisplatin in OVCAR-3 cells. Tumour Biol. 2011, 32:985-995.
29. Xu T., Yu C.Y., Sun J.J., et al. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck. Arch. Med. Res. 2011, 42:128-137.
30. Chiu C.Y., Kuo K.K., Kuo T.L., et al. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. Mol. Cancer Res. 2012, 10:415-427.
31. Rothhammer T., Poser I., Soncin F., et al. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 2005, 65:448-456.
32. Gordon K.J., Kirkbride K.C., How T., et al. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis 2009, 30:238-248.
33. Deng H., Ravikumar T.S., Yang W.L. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells. Cancer Lett. 2009, 281:220-231.